Static Chart BeiGene, Ltd. Hong Kong S.E.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:25 27/05/2024 BST			5-day change	1st Jan Change
92.55 ^HKD	+0.93%		-10.67%	-15.94%

05-24	BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa	MT
05-24	BeiGene, Ltd. Announces New Analyses for BRUKINSA® (zanubrutinib) At ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL	CI

Duration

Period